Zimmer Biomet Holdings Inc. (ZBH) News

Zimmer Biomet Holdings Inc. (ZBH): $112.46

1.70 (+1.53%)

POWR Rating

Component Grades








Filter ZBH News Items

ZBH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ZBH News Highlights

  • For ZBH, its 30 day story count is now at 11.
  • Over the past 24 days, the trend for ZBH's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about ZBH are TOP, TREE and UGI.

Latest ZBH News From Around the Web

Below are the latest news stories about ZIMMER BIOMET HOLDINGS INC that investors may wish to consider to help them evaluate ZBH as an investment opportunity.

Are Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Mixed Financials Driving The Negative Sentiment?

It is hard to get excited after looking at Zimmer Biomet Holdings' (NYSE:ZBH) recent performance, when its stock has...

Yahoo | September 20, 2023

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Yahoo | September 14, 2023

Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares Soar

Dexcom stock surged Wednesday after the company allayed concerns that popular weight-loss drugs would tamp on its diabetes devices.

Yahoo | September 6, 2023

Is Zimmer Biomet Holdings (ZBH) Modestly Undervalued? A Comprehensive Analysis

Delving into the intrinsic value of Zimmer Biomet Holdings (ZBH) based on its financial performance and market position

Yahoo | September 6, 2023

Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced key updates to the Company's Executive Leadership Team. Wilfred van Zuilen has been promoted to Group President, EMEA; Mark Bezjak was promoted to President of the Americas; and Chief Science, Technology and Innovation Officer Nitin Goyal, M.D. has been appointed to the Executive Leadership Team, all reporting directly to President and Chief Executive Officer Ivan Tornos.

Yahoo | September 5, 2023

Zimmer Biomet (ZBH) Business Recovery Continues Despite FX Woe

Zimmer Biomet (ZBH) is benefiting from increased provider capacity, resulting in backlog pull-through in the recent quarters.

Yahoo | September 5, 2023

Bearish Bets: 3 Stocks You Absolutely Should Think About Shorting This Week

Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Dollar Tree Inc. recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.

Yahoo | September 3, 2023

Here's Why You Should Retain Zimmer Biomet (ZBH) for Now

Investors are optimistic about Zimmer Biomet (ZBH) due to innovative new product launches and solid execution.

Yahoo | August 30, 2023

Nvidia upgraded, CrowdStrike downgraded: Wall Street's top analyst calls

Nvidia upgraded, CrowdStrike downgraded: Wall Street's top analyst calls

Yahoo | August 28, 2023

5 big analyst picks & cuts: Morgan Stanley trims CrowdStrike ahead of Q2

Here is your Pro Recap of the biggest analyst picks and cuts you may have missed today: upgrades at Forward Air, Zimmer Biomet, and UGI, and downgrades at CrowdStrike and L3Harris Technologies. Crowdstrike (NASDAQ:CRWD) shares fell more than 2% premarket today after Morgan Stanley downgraded the company to Equalweight from Overweight and cut its price target to $167.00 from $178.00 ahead of Q2/24 earnings announcement on Wednesday. Morgan Stanley believes that the consensus forecast for NNARR is overly optimistic at 6% year-over-year growth in Q3 and sees a downside to a 12% growth estimate in Q4.

Yahoo | August 28, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!